Last reviewed · How we verify

NCT06236945

HUTT to Assess Cardiac Autonomic Nervous Function

Recruiting now Last updated 26 September 2024
What this trial tests

trial in Autonomic Nervous System Diseases in 1,122 participants. Currently enrolling.

Timeline
31 January 2024
Primary endpoint
31 December 2025
31 December 2025

Quick facts

Lead sponsorThe First Hospital of Hebei Medical University
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment1,122
Start date31 January 2024
Primary completion31 December 2025
Estimated completion31 December 2025
Sites1 location across China

Conditions studied

Sponsor

The First Hospital of Hebei Medical University

Who can join

Adults 12 to 85, any sex, with Autonomic Nervous System Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Autonomic nervous system diseases can cause abnormalities in the circulatory system, leading to malignant arrhythmia and sudden cardiac death. Standardized, operable, and simplified diagnostic indicators are urgently needed to evaluate autonomic nervous function, particularly cardiac autonomic nervous function. The investigators use HUTT in order to provide data support for cardiac autonomic nervous system evaluation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Autonomic Nervous System Diseases

Currently open trials in the same condition.

Other The First Hospital of Hebei Medical University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06236945.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing